Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series: World’s leading Event Organizer
Aortic valve disease is a condition in which the valve between the main pumping chamber of your heart (left ventricle) and the main artery to your body (aorta) doesn't work properly. Aortic valve diseases sometimes may be a condition present at birth (congenital heart disease), or it may result from other causes.
Aortic stenosis is a narrowing of the aortic valve that limits the flow of blood from the left ventricle to the aorta. Over time, this causes the left ventricle to thicken, since it must work harder to pump blood through the narrowed opening. When the heart is stressed, such as during exercise, the overworked ventricle may not get enough blood. This can lead to chest pain, fainting, and even sudden death. In the long term, the ventricle may start to weaken, eventually causing heart failure.
While aortic stenosis may occur in any age group, most cases of aortic stenosis are seen in people in their 70s or 80s, usually as a result of the natural buildup of calcium in the valve, which gradually increases the valve’s rigidity. A relatively common birth defect called a bicuspid aortic valve, in which there are two leaflets instead of the normal three, can also lead to aortic stenosis. In people with this defect, the valve tends to calcify by the time they reach middle age. Less often, aortic stenosis stems from a case of rheumatic fever during childhood.
Aortic stenosis is readily treatable with valve replacement. There are two types of replacement, mechanical valves and tissue valves. At NYU, the vast majority of valve replacements are done with “third-generation” natural-tissue valves, which have been reengineered in recent years to cause fewer complications and to last longer than previous models. In certain circumstances, it is better for a patient to receive a mechanical valve. Mechanical valves generally do structurally deteriorate, an advantage over natural tissue valves. A major drawback, however, is that the patient must take Coumadin (a blood thinner) for life in order to prevent blood clots.
Most aortic valve replacements at NYU are performed with minimally invasive surgery. The primary advantages are less bleeding, reduced postoperative pain, and shorter recovery times, compared to traditional “open” surgery. Patients generally return to full activities in about three weeks. For older patients, minimally invasive surgery has an additional advantage: a significantly reduced risk of mortality during surgery. Our data, collected on more than 900 patients over age 70, shows that minimally invasive surgery reduces the operative risk in elderly patients by one half, compared to conventional surgical approaches.
OMICS International organises 1000+ Global Events every year in Conference series, on Clinical, Medicine, Pharma and Science & Technology every year across USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more scientific societies and Publishes 700+ open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members.
Scope and Importance:
Coronary angiography was used in 85.2% of patients before intervention. The Euro Heart Survey (EHS) program has been initiated order to provide quantitative information on cardiovascular disease. To prevent the incidence of cardiovascular (CV) disease, by implementing strategies to reduce the burden of CV risk factors and incidence of CV disease, and develop appropriate models for healthy CV lifestyle. 600,000 people die of heart disease in the United States. Cardiovascular diseases would be the largest cause of death and disability in by 2020 as per a World Health Organization (WHO) report. Smoke kills 600,000 people every year out of which 100,000 are children and 87% of deaths due to second hand smoke are due to cardiovascular diseases. Adult Cardiac Surgery provides state-of-the-art surgical care for patients with all types of adult cardiac disease. From 2007 to 2010, the number of coronary artery bypasses in Ohio dropped from 34,785 to 27,384. In that same time, the number of angioplasties (a less-invasive approach to eliminating blockages) increased from 12,047 to 15,050. Better medications have helped prevent blockages that require bypass surgery, and less-invasive approaches - particularly stents that hold vessels open. It has made collaboration with medical specialists.
The World Heart Federation (WHF) unites 200 members spanning 100 countries in the fight against cardiovascular disease Global Data research predicts the worldwide market for CMD devices will reach $1.2 billion by 2017. The global cardiovascular device industry is growing rapidly and is said that a growth of $15billion is made from 2010-2015 as per BCC research.Products included in this market are electrocardiograph monitoring equipment, which is set to see 4% growth by 2017 to be worth over $410 million.
6th Cardiology Conference
November 30-December 02, 2015 San Antonio, USA
July 14-15, 2016 Brisbane, Australia
Cardio Vascular Medicine Conference
April 04-06, 2016 Philadelphia, USA
June 06-07, 2016 London, UK
7th World Cardiothoracic Conference
March 29-30, 2016 Atlanta, USA
Ischemic Heart Diseases Conference
May 12-13, 2016 Chicago, USA
July 11-12, 2016 Philadelphia, USA
Hypertension & Treatment Conference
August 04-06, 2016 Toronto, Canada
10th Interventional Cardiology Conference
October 20-22, 2016 Rome, Italy
11th Cardiac Conference
October 6-8, 2016 Vancouver, Canada
12th World Cardiology Conference
October 10-12, 2016 Manchester, UK
13th European Cardiology Congress
October 24-26, 2016 Valencia, Spain
Cardiovascular Imaging Conference
November 10-12, 2016 Istanbul, Turkey
December 08-10, 2016 San Antonio, USA
BIT`s 6th International Congress of Cardiology (ICC-2014)
2015 American Society of Hypertension (ASH) Annual Scientific Meeting
CI Meeting 2015 - Innovations in Cardiovascular Interventions
ACC.15 - The American College of Cardiology 64th Annual Scientific Session & Expo
7th Annual Stroke and Cerebrovascular Disease Review 2015
Emergencies in Primary Care 2015
14th Annual Emergency Radiology Symposium 2014
18th International Conference on Cardiovascular System and Heart Health
International Conference for Innovations in Cardiovascular Systems (ICI2015)
15th Biennial Meeting of the International Society for Applied Cardiovascular Biology
World Congress of Cardiology & Cardiovascular Health
List of Associations
1. American Heart Association
2. British Cardiac Patients Association
3. Arquivos Brasileiros de Cardiologia
4. British Society of Echocardiography
5. American Society of Echocardiography
6. Canadian Society of Echocardiography
7. Canadian Cardiovascular Society
8. Austin Area Echo Society
9. The Iranian Society of Echocardiography
10. British Heart Foundation
11. Children’s Heart Foundation
12. The German Society of Cardiologists
13. Association for European Paediatric Cardiology
14. German Cardiac Society
15. European Association of Cardiothoracic Anaesthesiologists (EACTA)
16. European Society for Cardio-Vascular Surgery
17. Heart Failure Society of America
18. American Association of Heart Failure Nurses (AAHFN)
19. Association for European Paediatric Cardiology
20. European Heart Rhythm Association
List of Companies
1. Accellent Inc., USA
2. Admedes Schuessler GmbH, Germany
3. AorTech International plc, USA (Multinational)
4. Arbor Surgical Technologies, Inc. USA
5. ATS Medical, Inc. USA
6. AutoTissue GmbH ,Germany
7. Boston Scientific Corporation, USA
8. CarboMedics Inc. Italy (Belgium, Brazil, Canada, China, Dominican Republic, France, Germany, Italy, and the United States.)
9. Cardiac Dimensions Inc. USA, Germany, Australia
10. Cardiosolutions, Inc.,USA
12. Vasomedical, Inc.
15. Cardiac Dimensions
This page will be updated regularly.
This page was last updated on 05th Apr, 2016
1-702-508-5200 Ext:8031, 8041
1-702-508-5200 Ext:8045, 8047
Immunology & Microbiology Conferences
Nursing and Healthcare Conferences
Clinical and Biochemistry Conferences
1-702-508-5200 Ext:8031, 8037
Material Science Conferences
Genetics & Mol Biology Conferences
Media Partners | Advertising